Product Information
BELSOMRA 5 MG TABLET is a brand product labeled by Merck Sharp & Dohme LLC, priced at $15.1831 per EA under NDC 00006000530. Its NADAC has been published 554 times since Nov 18, 2015.
Strength
5 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006000530
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUVOREXANTApproval Type
New Drug (NDA)
FDA Application
NDA204569On Market Since
8/29/2014
Pharmacological Classes
Price Statistics
The NADAC for BELSOMRA 5 MG TABLET has been published 554 times since Nov 18, 2015, and over the history we have for it it has risen 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $15.1831 per EA |
|---|---|
| All-time high | $15.2329 (May 13, 2026) |
| All-time low | $8.4294 (Dec 23, 2015) |
| 52-week high | $15.2329 |
| 52-week low | $14.8689 |
| Median price | $12.1844 |
| Average price | $12.1028 |
| Largest weekly change | +8.0% (Jan 17, 2018) |
| Weeks tracked | 554 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the suvorexant market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of BELSOMRA 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BELSOMRA 5 MG TABLET, manufactured by Merck Sharp & Dohme LLC, is $15.1831 per EA (NDC 00006000530), effective Jun 24, 2026.
How has the price of BELSOMRA 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BELSOMRA 5 MG TABLET has risen 80.0%. It has been tracked across 554 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for BELSOMRA 5 MG TABLET?
Since Nov 18, 2015, the NADAC for BELSOMRA 5 MG TABLET has ranged from a low of $8.4294 (Dec 23, 2015) to a high of $15.2329 (May 13, 2026), with a median of $12.1844 per EA.
Are there cheaper alternatives to BELSOMRA 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BELSOMRA 5 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures BELSOMRA 5 MG TABLET?
BELSOMRA 5 MG TABLET (NDC 00006000530) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification